|
ImQuest Life Sciences has broad-based interest in infectious disease and the development of drugs which inhibit these organisms through novel targets and means of intervention. Although vaccine development has been successful in many areas of infectious disease, significant unmet medical needs still remain with organisms such as HIV and hepatitis C virus. In many cases, despite the presence of effective vaccines, great numbers of people remain chronically infected with organisms that will cause significant long term health problems, such as with hepatitis. ImQuest Life Sciences is working with our partners to develop new therapies for infectious disease caused by viral, bacterial and fungal pathogens, especially in the areas of HIV, hepatitis B and C virus, influenza and other respiratory pathogens, herpes viruses and other emerging or re-emerging viral, bacterial and fungal infections.
|
